Skip to main content

respiratory disease diagnostic app

By Dean Koh | 11:33 pm | February 23, 2020
The news follows after the company’s ResAppDx-EU version 2 smartphone app was approved by the Australian TGA as a Class IIa medical device.
By Dave Muoio | 05:15 pm | September 04, 2018
With these data, CEO Tony Keating said the company will be pursuing European and Australian regulatory submissions.